NZ506908A - Cephalosporines having cyclic aminoguanidine substituents as antibiotics - Google Patents

Cephalosporines having cyclic aminoguanidine substituents as antibiotics

Info

Publication number
NZ506908A
NZ506908A NZ506908A NZ50690899A NZ506908A NZ 506908 A NZ506908 A NZ 506908A NZ 506908 A NZ506908 A NZ 506908A NZ 50690899 A NZ50690899 A NZ 50690899A NZ 506908 A NZ506908 A NZ 506908A
Authority
NZ
New Zealand
Prior art keywords
cephalosporines
antibiotics
substituents
cyclic
cyclic aminoguanidine
Prior art date
Application number
NZ506908A
Other languages
English (en)
Inventor
Gerd Ascher
Werner Heilmayer
Johannes Ludescher
Original Assignee
Biochemie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochemie Gmbh filed Critical Biochemie Gmbh
Publication of NZ506908A publication Critical patent/NZ506908A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
NZ506908A 1998-03-23 1999-03-19 Cephalosporines having cyclic aminoguanidine substituents as antibiotics NZ506908A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0051598A AT406772B (de) 1998-03-23 1998-03-23 Antibakterielle 7-acylamino-3-iminomethyl- cephalosporine und verfahren zu deren herstellung
PCT/EP1999/001853 WO1999048896A1 (en) 1998-03-23 1999-03-19 Cephalosporines having cyclic aminoguanidine substituents as antibiotics

Publications (1)

Publication Number Publication Date
NZ506908A true NZ506908A (en) 2003-04-29

Family

ID=3492649

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ506908A NZ506908A (en) 1998-03-23 1999-03-19 Cephalosporines having cyclic aminoguanidine substituents as antibiotics

Country Status (25)

Country Link
US (1) US6440957B1 (cg-RX-API-DMAC10.html)
EP (2) EP1930335A1 (cg-RX-API-DMAC10.html)
JP (1) JP2002507616A (cg-RX-API-DMAC10.html)
KR (1) KR100696422B1 (cg-RX-API-DMAC10.html)
CN (1) CN1188418C (cg-RX-API-DMAC10.html)
AR (1) AR015248A1 (cg-RX-API-DMAC10.html)
AT (1) AT406772B (cg-RX-API-DMAC10.html)
AU (1) AU749735B2 (cg-RX-API-DMAC10.html)
BR (1) BR9908960A (cg-RX-API-DMAC10.html)
CA (1) CA2324953C (cg-RX-API-DMAC10.html)
CO (1) CO5080739A1 (cg-RX-API-DMAC10.html)
HU (1) HUP0101603A3 (cg-RX-API-DMAC10.html)
ID (1) ID26567A (cg-RX-API-DMAC10.html)
IL (2) IL138477A0 (cg-RX-API-DMAC10.html)
MY (1) MY119841A (cg-RX-API-DMAC10.html)
NO (1) NO20004760L (cg-RX-API-DMAC10.html)
NZ (1) NZ506908A (cg-RX-API-DMAC10.html)
PE (1) PE20000360A1 (cg-RX-API-DMAC10.html)
PL (1) PL343094A1 (cg-RX-API-DMAC10.html)
RU (1) RU2245884C2 (cg-RX-API-DMAC10.html)
SK (1) SK14152000A3 (cg-RX-API-DMAC10.html)
TR (1) TR200002749T2 (cg-RX-API-DMAC10.html)
TW (1) TWI250983B (cg-RX-API-DMAC10.html)
WO (1) WO1999048896A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200004850B (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6693095B2 (en) * 1997-04-01 2004-02-17 Biochemie Gesellschaft M.B.H. Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates
DE102007052891A1 (de) 2007-11-02 2009-05-07 Evonik Degussa Gmbh Verfahren zur Stabilisierung von olefinisch ungesättigten Monomeren
DE102013204950A1 (de) 2013-03-20 2014-09-25 Evonik Industries Ag Verfahren und Zusammensetzung zur Inhibierung der Polymerisation von Cyclopentadienverbindungen
ES2624415T3 (es) 2014-09-08 2017-07-14 Evonik Degussa Gmbh (Tio)acetales fenólicos como agentes inhibidores de la polimerización de monómeros olefínicamente insaturados
TWI669317B (zh) 2014-09-22 2019-08-21 德商贏創德固賽有限責任公司 反應性單體的改良製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE943408C (de) * 1953-03-31 1956-05-17 Bayer Ag Verfahren zur Darstellung von Bisguanylhydrazonen
FI851934L (fi) * 1984-05-30 1985-12-01 Ici Plc Kefalosporinderivat.
GB8721568D0 (en) * 1987-09-14 1987-10-21 Fujisawa Pharmaceutical Co Cephem compounds
ATE233268T1 (de) * 1995-05-11 2003-03-15 Biochemie Gmbh Antibakterielle cephalosporinverbindungen
BR9807913A (pt) * 1997-04-01 2000-02-22 Biochemie Gmbh 7-acilamino-3-(metilhidrazono)metil cefalosporinas substituìdas antibacterianas e intermediários

Also Published As

Publication number Publication date
HUP0101603A3 (en) 2002-10-28
NO20004760D0 (no) 2000-09-22
TWI250983B (en) 2006-03-11
PL343094A1 (en) 2001-07-30
ATA51598A (de) 2000-01-15
AU3518899A (en) 1999-10-18
BR9908960A (pt) 2000-12-05
IL138477A (en) 2007-06-17
WO1999048896A1 (en) 1999-09-30
AR015248A1 (es) 2001-04-18
AT406772B (de) 2000-08-25
CN1294593A (zh) 2001-05-09
MY119841A (en) 2005-07-29
KR100696422B1 (ko) 2007-03-20
NO20004760L (no) 2000-11-21
HUP0101603A2 (hu) 2001-12-28
EP1930335A1 (en) 2008-06-11
US6440957B1 (en) 2002-08-27
CO5080739A1 (es) 2001-09-25
SK14152000A3 (sk) 2001-05-10
ID26567A (id) 2001-01-18
JP2002507616A (ja) 2002-03-12
AU749735B2 (en) 2002-07-04
RU2245884C2 (ru) 2005-02-10
TR200002749T2 (tr) 2000-12-21
EP1082326A1 (en) 2001-03-14
PE20000360A1 (es) 2000-05-17
KR20010074666A (ko) 2001-08-08
ZA200004850B (en) 2002-02-27
CA2324953C (en) 2008-05-13
IL138477A0 (en) 2001-10-31
CA2324953A1 (en) 1999-09-30
CN1188418C (zh) 2005-02-09

Similar Documents

Publication Publication Date Title
CA2418614A1 (en) Phosphonocephem compound
CA2325741A1 (en) Urea derivatives having tnf- .alpha. production inhibitory effects
AU7125291A (en) Inhibitors of nitric oxide biosynthesis
MY133731A (en) Mutilin derivatives and their use as antibacterials
MY118904A (en) 4-oxo-1, 4-dihydro-3-quinolinecarboxamides as antiviral agents
WO2001077107A8 (en) Oxazole derivatives and their uses as tyrosine kinase inhibitors
EP1485377B8 (en) Pyranones useful as atm inhibitors
BR0107645A (pt) Oxazolidinona tiamidas com substituintes de piperazina amida
GB0021421D0 (en) Compounds
TW200517132A (en) Stable aqueous antiplaque oral compositions
BG105919A (en) Erythromycin derivatives
ATE141272T1 (de) Beta-lactam-verbindungen und ihre herstellung
ATE233264T1 (de) Polynalbuphinderivat
TW372972B (en) Antiretroviral acyl compounds
EP0469156A4 (en) Glutathione derivative
CA2221946A1 (en) Production process of cyclic compound
MY141869A (en) Mouth rinse compositions
EP1134219A4 (en) AMINOMETHYLPYRROLIDINE DERIVATIVES SUBSTITUTED BY CYCLOALKYLES
MY119841A (en) Cephalosporines having cyclic aminoguanidine substituents as antibiotics.
KR950704333A (ko) 신규한 세펨 유도체(novel cephem derivatives)
NZ336091A (en) Aqueous disinfecting cleaning composition
AU3565700A (en) Antibacterial agents
GB2271718B (en) Antimicrobial agents comprising polyquaternary ammonium compounds
WO2000064902A3 (en) Process for the preparation of calanolide precursors
NZ333854A (en) Intermediates for the preparation of 2-imidazoline-5-ones

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
ASS Change of ownership

Owner name: SANDOZ AG, CH

Free format text: OLD OWNER(S): BIOCHEMIE GESELLSCHAFT MBH

RENW Renewal (renewal fees accepted)